APTAMER仿:

Zhilan Zhou1,2, Yichang Liu3, Ya Wang2

  • 1Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, 300072, China.

Nature communications
|April 25, 2025
PubMed
概括

我们开发了Aptamer指导的酸酶招募基因组 (Apt-PRCs) 来去化细胞表面受体,通过向受体氨酸激酶来克服癌症药物耐药性的新策略.